Kadir Ozkan

Kadir Ozkan is an accomplished scientist with extensive experience in cell biology and therapeutic research. Currently serving as Associate Director and Senior Scientist at Novo Nordisk, Kadir focuses on developing complex in vitro human cell models to enhance drug discovery. Previously, as Principal Scientist at Flagship Pioneering, Kadir provided strategic leadership in advancing non-viral nucleic acid therapeutics. Kadir's experience also includes leading preclinical programs at SQZ Biotechnologies for autologous cell therapy targeting Parkinson’s Disease and Multiple Sclerosis. At Harvard University, Kadir's work as a postdoctoral fellow concentrated on neuronal subtype development and regeneration, and involvement in teaching and mentoring at various academic levels. Kadir holds a Ph.D. in Molecular Biology and Genetics from Boğaziçi University, complemented by a visiting Ph.D. tenure at Harvard University.